BRIEF published on 09/30/2026 at 00:42, 5 hours 39 minutes ago GenSight Biologics Reports 2026 Interim Financial Results Funding Challenges GenSight Biologics Early Access Programs Financial Results 2026 Clinical Trials Update
PRESS RELEASE published on 09/30/2026 at 00:37, 5 hours 44 minutes ago Inside Information / News release on accounts, results GenSight Biologics reports interim financial results for the first half of 2026, including revenue of €(1.2) million, highlighting successful manufacturing technology transfer and progress in clinical studies Revenue Clinical Studies GenSight Biologics Interim Financial Results Manufacturing Technology Transfer
BRIEF published on 09/08/2026 at 07:35, 21 days 22 hours ago GenSight Biologics: Review and Outlook as of September 2026 GenSight Biologics Gene Therapies REVISED STUDY LUMEVOQ® Manufacturing Access Programs
PRESS RELEASE published on 09/08/2026 at 07:30, 21 days 22 hours ago Inside Information / Other news releases GenSight Biologics provides business updates on manufacturing, clinical activities, and financial status for September 2026, including progress on gene therapy treatments Financial Updates Manufacturing Business Updates Clinical Activities GenSight Biologics
BRIEF published on 07/08/2026 at 19:16, 2 months 21 days ago GenSight Biologics presents its financial situation and therapeutic advances Treasury GenSight Biologics Phase III RECOVER Early Access GS010/LUMEVOQ®
BRIEF published on 07/08/2026 at 19:16, 2 months 21 days ago GenSight Biologics Announces Cash Position and Business Updates Cash Position Clinical Trials Business Updates Early Access Programs Manufacturing Process
PRESS RELEASE published on 07/08/2026 at 19:11, 2 months 21 days ago Inside Information / News release on accounts, results GenSight Biologics reports cash position updates as of June 30, 2026, along with business developments, including proceeds from early access programs and manufacturing process improvements Cash Position Business Updates GenSight Biologics Early Access Programs Manufacturing Process
BRIEF published on 04/28/2026 at 20:40, 5 months 1 day ago GenSight Biologics Schedules Annual General Meeting for May 2026 Annual General Meeting Regulatory Compliance Shareholder Information Investor Relations Gene Therapy
BRIEF published on 04/28/2026 at 20:40, 5 months 1 day ago GenSight Biologics announces its 2026 Combined General Meeting Shareholders Gene Therapy General Assembly Preparatory Documents GenSight Biologics
PRESS RELEASE published on 04/28/2026 at 20:35, 5 months 1 day ago Inside Information / Other news releases GenSight Biologics to hold Annual General Meeting on May 19, 2026, in Paris. Shareholders can access preparatory documents online. Meeting details and documents available on company website Annual General Meeting Shareholders Preparatory Documents Meeting Details GenSight Biologics
Published on 09/30/2026 at 02:05, 4 hours 16 minutes ago Annual Report for the Year Ended 30 June 2026
Published on 09/30/2026 at 01:45, 4 hours 36 minutes ago Tungsten Eagle Development Corp. (Formerly Patriot Resources Corp.) Completes Fundamental Change, Closes $5,000,000 Concurrent Financing and to Commence Trading on the Canadian Securities Exchange
Published on 09/30/2026 at 00:55, 5 hours 26 minutes ago Core Silver Announces Private Placement of up to $1,000,000
Published on 09/30/2026 at 00:45, 5 hours 36 minutes ago Clean Air Metals Files Interim Financial Statements for the Six Months Ended July 31, 2026
Published on 09/29/2026 at 23:20, 7 hours 1 minute ago EvokAI Creative Labs to Transfer Listing to NEX
Published on 09/30/2026 at 00:05, 6 hours 15 minutes ago New study reveals major impact of climate change on skin health worldwide
Published on 09/30/2026 at 00:05, 6 hours 15 minutes ago Almost 95% of viral Korean skincare and 'glass skin' TikTok videos contain misleading claims, new study shows
Published on 09/29/2026 at 21:30, 8 hours 50 minutes ago Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's Aurora Facility
Published on 09/29/2026 at 19:47, 10 hours 33 minutes ago EQS-Adhoc: Marley Spoon Group SE: MARLEY SPOON GROUP SE REPORTS H1 2026 RESULTS AND GUIDANCE FOR 2026
Published on 09/29/2026 at 19:15, 11 hours 5 minutes ago Pensão Amor: Discover Lisbon's Most Surprising Hotel
Published on 09/28/2026 at 17:54, 1 day 12 hours ago Reporting on share buyback transactions carried out between September 21 and September 25, 2026
Published on 09/28/2026 at 17:35, 1 day 12 hours ago Disclosure of transactions in own shares from September 21 to September 25, 2026
Published on 09/28/2026 at 08:02, 1 day 22 hours ago Saint-Gobain signs renewable electricity purchase agreement in the United Kingdom
